This is a preview of subscription content, log in via an institution to check access.
Reference
Choi EJ, et al. Cost effectiveness of trivalent and quadrivalent influenza vaccines in 50- to 64-year-old adults in Korea. Vaccine : 9 Jun 2020. Available from: URL: http://dx.doi.org/10.1016/j.vaccine.2020.05.065
Rights and permissions
About this article
Cite this article
Quadrivalent influenza vaccine cost effective in South Korea. PharmacoEcon Outcomes News 856, 27 (2020). https://doi.org/10.1007/s40274-020-6927-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6927-x